Tanya Dorff, Associate Professor of Clinical Medicine at USC Keck School of Medicine, shared a post on X:
“Very exciting to kick off S2427 bladder preservation after neoadjuvant therapy using radiation plus pembrolizumab – now open to accrual! Congrats to Dr Ballas, Daneshmand and the whole team! Many thanks to patient advocate for keeping patient voice central to design.”
More from Tanya Dorff on OncoDaily.